Germany· DE-A57-599904e738c6fb8c
Hiberix
A medicinal product containing haemophilus type b conjugate vaccine (tetanus toxoid conjugate), registered in Germany by Glaxosmithkline Gmbh & Co. Kg.
Checked against EMA Article 57 (European Union) on
Informational only — not a medical device.
The record
At a glance
EMA Article 57 (European Union)- Active substance
- Haemophilus Type B Conjugate Vaccine (Tetanus Toxoid Conjugate)
- Manufacturer
- Glaxosmithkline Gmbh & Co. Kg
- Country
- Germany (DE)
- ATC code
- —
- Reimbursed
- Not published by this register
- Source register
- EMA Article 57 (European Union)
- Last checked
- August 5, 2026
Packs & prices · 0
No packs listed by the register for this record.
Regulatory notes
No shortage, Orange Book or US label notes for this record.
Same medicine, other countries
Haemophilus type b conjugate vaccine (tetanus toxoid conjugate) in 8 other countries
What each register calls a product with the same active substance — salts and hydrates count as the same.
- BelgiumInfanrix (DTPa)GlaxoSmithKline Biologicals
- CzechiaTETAVAXSanofi Winthrop Industrie, Gentilly
- FinlandEquilis TeIntervet International B.V.
- Japan沈降破傷風トキソイド
- NorwayAct-HibSanofi Winthrop Industrie
- PolandSzczepionka tężcowa adsorbowana (T)Wytwórnia Surowic i Szczepionek Biomed Sp. z o.o.
- SwedenAct-HIB Pulver och vätska till injektionsvätska, lösningSanofi Winthrop Industrie
- NetherlandsTetanusvaccin, suspensie voor injectie > 40 IEBilthoven Biologicals B.V.
Authorised across Europe · EMA
The same active substance is authorised in 3 EEA countries. Names it is sold under:
- Hungary · Tetatox
- Netherlands · Tetanusvaccin
- Slovakia · Alteana Vakcína Proti Tetanu (Adsorbovaná)
Source: European Medicines Agency, Article 57 product data.
Sourced from a public register and reproduced with attribution. Drug Database is not affiliated with, endorsed by, or a partner of EMA Article 57 (European Union). This is an informational data service and not a medical device — verify against the official source of record before any clinical decision.
For developers
The same record over the API, and the raw payload
GET /v1/drugs/7bb373c7-38bb-4620-b8fb-c0294d7cdb24 GET /v1/drugs/7bb373c7-38bb-4620-b8fb-c0294d7cdb24?format=fhir
Every response carries last_synced_at, so freshness is a field rather than a promise. Below is exactly what the ingestion wrote, before any presentation — the same JSON the API returns under payload.
{
"pzn": null,
"route": "Intramuscular Use, Subcutaneous Use",
"source": "ema_art57_de",
"ma_number": null,
"substance": "Haemophilus Type B Conjugate Vaccine (Tetanus Toxoid Conjugate)",
"atc_from_source": null,
"authorisation_country": "Germany"
}See everything about haemophilus type b conjugate vaccine (tetanus toxoid conjugate).
This page is the registration. A free account adds the label text as the regulator wrote it, what it costs per daily dose across the markets that publish a price, a feed of what changes in the registers, and an assistant that answers with its sources. Interaction severity is free; mechanism and management are on the Growth plan. No card, nothing to install.